Howard University Investigators, Drs. Nekhai, Haddad, and Burke, receive Research Centers in Minority Institutions (RCMI)-CFAR Supplemental Grants | |
From left to right: Dr. Sergai Nekhai, Dr. Georges Haddad, and Dr. Mark Burke | |
Howard University faculty Dr. Sergai Nekhai, DC CFAR Basic Sciences Core Director, Dr. Georges Haddad, Director of the Investigator Development Program for the Howard University RCMI program, and Dr. Mark Burke, DC CFAR Developmental Core Co-Director have been awarded Research Center in Minority Institutions (RCMI)-CFAR supplemental awards to support HIV/AIDS research.
The NIH established the RCMI program in 1985 in response to Congressional interest in expanding the national capacity for research in the health sciences, minority health, and health disparities research. Howard University is one of 22 RCMI centers across the United States. These supplemental awards are intended to spur collaboration between RCMI centers and CFARs.
Dr. Nekhai's project is entitled “Increased risk of HIV-1 infection among African Americans with Ferroportin Q248H mutation.” Dr. Seble Kassaye (GU) is a co-Investigator in this project and she will facilitate access and screening of MACS cohort participants. Drs. Haddad and Burke's project is entitled “The cardiovascular effects of gestational and perinatal combined antiretroviral therapy (cART),” and this project builds upon Dr. Haddad's DC CFAR 2022 Pilot Award, "Effects of cART on the Heart."
| |
Dr. Manya Magnus, DC CFAR Co-Director, named Chair of Department of Epidemiology at GW Milken Institute School of Public Health | |
On January 2nd, The Milken Institute School of Public Health at the George Washington University (GW) announced that Manya Magnus, PhD, MPH, had been named Chair of the Department of Epidemiology.
Dr. Magnus serves as Co-Director of the DC CFAR, Clinical Trials Unit (CTU) Leader and contact MPI for the DC CTU and the Evaluation Lead for the CFAR Diversity, Equity and Inclusion Pathway Initiative (CDEIPI) Program. Previously Dr. Magnus served as the Co-Director of the DC CFAR Clinical and Population Sciences Core.
Dr. Magnus's expertise includes clinical trials research, biomedical and structural interventions to prevent HIV transmission, advanced epidemiologic methods and analysis, research design, implementation, and regulatory coordination, program evaluation, and community engagement in HIV research.
Please read the full story here. Congratulations to Dr. Magnus!
| |
DC CFAR CPS Core Conversations: "The impact of acute and early ART initiation on autologous neutralizing antibody responses to HIV-1." by Dr. Katherine Bar, TODAY, Wed, Jan 24, from 5:00-6:00PM EST | |
Please join us for an upcoming CPS Core Conversation TODAY, January 24, from 5:00-6:00 pm ET. This webinar will feature Dr. Katharine Bar, Associate Professor of Medicine at the University of Pennsylvania within the Division of Infectious Diseases, and Director of the Penn Center for AIDS Research Virus and Reservoirs Core.
Dr. Bar's presentation will be on "The impact of acute and early ART initiation on autologous neutralizing antibody responses to HIV-1." Please find more information at the link here and register at the link below.
Register here
| | |
DC CFAR Traditional Pilot Awards 101 Session, Tuesday, January 30, from 3:00 - 4:00pm via Zoom | |
Please join us for the virtual DC CFAR Pilot Awards 101 session hosted by the Developmental Core on Tuesday, January 30, from 3:00-4:00 pm ET.
This event will provide an overview of the DC CFAR and an orientation to the Traditional Pilot Awards program. The Traditional Pilot Awards program aims to provide pilot funds on a competitive basis to early-stage and new HIV/AIDS investigators to assist them in the development of their NIH-funded research careers.
The agenda will include an overview of this DC CFAR funding opportunity and the core services available for its members, an opportunity to share research goals and interests, and a discussion with the Developmental Core Directors.
Register here for the virtual session to receive the Zoom information
| |
DC CFAR Social and Behavioral Sciences Core Panel: Incorporating Policy Perspectives in HIV Research, Jan 31, 10-11:30AM, via Zoom | |
Please join the Social and Behavioral Sciences (SBS) Core for a panel discussion entitled "Incorporating Policy Perspectives into HIV Research, on Wednesday, January 31st, from 10-11:30AM via Zoom.
This panel will feature Dr. Kim Blankenship (AU), Developmental Core Co-Director and Distinguished Professor of Sociology, Professor Naomi Seiler (GW), Professor of Health Policy and Management, and Dr. Tamara Taggart (GW), Associate Director of the SBS Core and Assistant Professor of Prevention and Community Health. This panel will be moderated by Dr. David Huebner (GW), SBS Core Co-Director and Professor of Prevention and Community Health. Panelists will be discussing the how of incorporating policy aims into HIV research grants and why these aims are important.
Join using the Zoom link here.
| | |
Do you have an event you would like to see included in the next edition of the Community Spotlight? We invite any news or updates from the DC CFAR community and encourage you to send information that may be of interest to CFARinDC@gmail.com. | |
|
CROI: Conference on Retroviruses and Opportunistic Infections 2024 (Abstract Submission here)
March 3-6, 2024
Denver, CO
Inter-CFAR Substance Use Research Community (I-SURC) Networking Meeting (During CROI) - Are you attending CROI and interested networking with other substance use researchers? Register now!
March 3, 2024
Denver, CO
Save the Date – National 2024 Ryan White Conference on HIV & Treatment (AIDSWatch)
March 17-19, 2024
Washington, DC
Save the Date: MACC School of Nursing (SON) Conference
May 2-3, 2024
Baltimore, MD
SYNC 2024: Registration Now Open & Call for Abstracts
May 29-31, 2024
Washington, DC
IAS 2024
July 22-26
Munich, Germany
National LGBTQ+ Health Conference
August 15-17, 2024
Atlanta, GA
2024 National Ryan White Conference on HIV Care & Treatment
August 20-23, 2024
For more DC CFAR events please see the calendar here.
| |
FUNDING, TRAINING, & MENTORING OPPORTUNITIES & SEMINARS | |
|
Intervention Research to Improve Native American Health (IRINAH) Program, Thursday, Jan 25, at 1pm EST
A webinar on Intervention Research to Improve Native American Health (IRINAH) Program is scheduled for January 25, 2024 at 1:00-2:30pm EST to discuss the new Notices of Funding Opportunity (NOFOs)—R01 PAR-23-298, R21 PAR-23-299, and R34 PAR-23-285. Webinar Goals:
-
Explain the goals and objectives of the NOFOs
-
Highlight what’s new with the IRINAH NOFOs relative to prior IRINAH NOFOs, including the addition of an R34 mechanism and non-responsiveness criteria
-
Answer questions from attendees
Register here: https://nih.zoomgov.com/webinar/register/WN_IsBBihjJT0ipI73z0vYIhQ#/registration
ISCI EHE Supplement Project Webinar Series, Jan 31, 2024, 1:00PM ET
The Implementation Science Coordination Initiative (ISCI) is excited to announce a new webinar series which will feature an array of topics. This new webinar series will feature EHE Supplement Project presentations and aims to create an engaging opportunity for the EHE network to foster collaboration and extensive knowledge sharing about project findings, accomplishments, and more! Register here.
JIAS Symposium: Advancing Use of Long-Acting HIV Treatment and Prevention Regimens, Friday, Feb 2, 2024, 10am EST
The symposium will highlight some key findings from the supplement published in July 2023 and will offer a comprehensive overview of the ongoing research on long-acting regimens. It will include community perspectives, explore future directions, and conclude with a panel discussion. Register here
Intersectionality Summer Intensive, Application due Feb 9, 2024
The Intersectionality Training Institute is accepting applications for the third cohort of its Intersectionality Summer Intensive. The Intersectionality Summer Intensive (ISI 2024) is a weeklong in-person training designed for researchers interested in learning how to apply intersectionality to their qualitative, quantitative, or mixed methods research projects. Lisa Bowleg, PhD, MA and Greta Bauer, PhD, MPH, leading experts of intersectionality, developed ISI ’24 to be a transformative, intellectually stimulating, and engaging environment where researchers and practitioners can meet, learn, and build community with other researchers, scholars, and practitioners who are passionate about applying intersectionality to health equity research, including HIV-related projects. ISI ’24 will be held in Philadelphia, PA from July 8 through July 12, 2024. We are thrilled to share that Dr. Patricia Homan will be our distinguished guest and facilitator. Dr. Homan, Associate Professor of Sociology and Associate Director of the Public Health Program at Florida State University, is in the vanguard of research and scholarship on structural intersectionality and health equity research. The deadline to apply is Friday, February 9th at 11:59 PM EST. Apply here or visit the ITI ’24 site at https://www.intersectionalitytraining.org/summer-intensive/. Have questions? Email the Intersectionality Training Institute at info@intersectionalitytraining.org.
NEW - Michigan Integrative Well-Being and Inequality (MIWI) Training Program, Application due Feb 15, 2024
Come train with us! The Michigan Integrative Well-Being and Inequality (MIWI) Training Program is accepting applications through 2/15/2024. We provide early career researchers (MD, PhD, ScD, DrPH, EdD, etc.) applied training on innovative methods for understanding the links between mental and physical health, with a focus on how these links relate to minority health and health disparities. We provide mentorship from senior experts, and the opportunity to learn with like-minded, creative peers. Learn more and apply here.
Applications for the Latino Scholars for HIV/AIDS Research Education (SHARE) 2024 Summer Program, Apply Now
The Latino SHARE program is an innovative 10-week summer mentored internship and learning experience for eligible undergraduate students from Hispanic/Latino communities. Based in Washington, DC at the George Washington University, the goal of this program is to support Hispanic/Latino undergraduates interested in pursuing further studies and careers in HIV/AIDS and substance abuse related research. The application deadline is February 16, 2024, at 11:59 PM EST. Learn more about the SHARE program and how to apply at latinoshare.gwu.edu
| |
NIH FUNDING OPPORTUNITIES
| |
|
HIV Cure-Related Research in Diverse Populations
Funding Opportunity Number: NOT-AI-23-046
Posting Date: June 23, 2023
Opening Date: September 07, 2023
Close Date: May 08, 2026
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-225
Posting Date: June 27, 2023
Opening Date: August 07, 2023
Close Date: Various – See announcement
Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DK-25-001
Posting Date: November 30, 2023
Opening Date: February 20, 2024
Close Date: Various – See announcement
Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity Number: RFA-AI-23-060
Posting Date: October 25, 2023
Opening Date: February 13, 2024
Close Date: March 14, 2024
Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
Funding Opportunity Number: PAR-23-112
Posting Date: January 31, 2023
Opening Date: February 24, 2023
Close Date: Various – See announcement
Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-018
Posting Date: August 21, 2023
Opening Date: July 5, 2024
Close Date: August 2024
Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-001
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
Funding Opportunity Number: RFA-OD-23-018
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
| |
|
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-297
Posting Date: September 19, 2023
Opening Date: December 07, 2023
Close Date: Various – See announcement
Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-22-185
Posting Date: May 27, 2022
Opening Date: December 07, 2023
Close Date: Various – See announcement
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-198
Posting Date: June 02, 2023
Opening Date: September 13, 2023
Close Date: Various – See announcement
Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-061
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-060
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
Funding Opportunity Number: NOT-MH-23-275
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
Funding Opportunity Number: NOT-CA-23-070
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
| |
Click here for additional funding opportunities available from the National Institutes of Health. | |
The DC CFAR is an NIH funded program (P30AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NINR, NIMHD, FIC, and OAR. The content isthe responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. | | |
| | | |
